Insulin-like Growth Factor I Receptor Signaling

胰岛素样生长因子 I 受体信号转导

基本信息

项目摘要

In addition to being important for normal fetal and postnatal growth, there is increasing evidence that insulin-like growth factors I and II (IGF-I, IGF-II) also support the growth of certain cancers. Biologic responses to IGF-I and IGF-II are signaled by the IGF-I receptor. Therefore, we are focusing our research effort on understanding signaling by the IGF-I receptor. We have used the yeast two-hybrid system to identify new binding partners for the IGF-I receptor. We have inserted the cytoplasmic domain of the IGF-I receptor into the LexA DNA binding vector. Poly A mRNA was prepared from the human osteosarcoma cell line, MG-63, and given to a commercial laboratory for preparation of a cDNA library in the yeast two-hybrid activation domain vector. The library screen identified IGF-I receptor binding partners that we and others had previously identified (p85 regulatory subunit of PI3-K, p66 Shc, Grb10, 14-3-3 beta and zeta, SOCS-1, SH2-B/PSM, RACK-1) as well as new interactors (STAT5a, GIPC, Ril, and 4 clones that are not fully characterized). We are focusing on GIPC which represented 25% of the most strongly interacting clones. GIPC did not interact with the insulin receptor in the yeast two hybrid assay. GIPC is a 333 amino acid protein with a central SH2 domain. Mutational analysis in the yeast two-hybrid system showed that GIPC PDZ domain binds to the carboxy tail of the IGF-I receptor. GIPC dimerizes and the dimerization domain has been shown to include the amino terminal domain as well as a portion of the PDZ domain. IGF-I receptor constructs that have been mutated to prevent GIPC binding have been transfected into IGF-I receptor null mouse embryo fibroblasts in order to explore the function of GIPC in IGF-I receptor signaling. We have developed a mouse monoclonal antibody (4G11) directed against the human IGF-I receptor. This monoclonal antibody blocks the binding of radiolabeled IGF-I to MCF-7 breast cancer cells and MG-63 osteosarcoma cells and downregulates the receptor.
除了对正常胎儿和出生后的生长很重要外,越来越多的证据表明胰岛素样生长因子I和II(IGF-I,IGF-II)也支持某些癌症的生长。对IGF-I和IGF-II的生物学应答由IGF-I受体发出信号。因此,我们的研究重点是了解IGF-I受体的信号传导。 我们已经使用酵母双杂交系统,以确定新的结合伙伴的IGF-I受体。我们已经将IGF-1受体的胞质结构域插入到莱克萨DNA结合载体中。从人骨肉瘤细胞系MG-63中制备Poly A mRNA,并将其提供给商业实验室用于制备酵母双杂交激活结构域载体中的cDNA文库。文库筛选鉴定了我们和其他人先前鉴定的IGF-I受体结合配偶体(PI 3-K的p85调节亚基、p66 Shc、Grb 10、14-3-3 β和zeta、SOCS-1、SH 2-B/PSM、RACK-1)以及新的相互作用物(STAT 5 a、GIPC、Ril和4个未完全表征的克隆)。我们专注于GIPC,它代表了25%的最强相互作用的克隆。在酵母双杂交试验中,GIPC不与胰岛素受体相互作用。GIPC是一种由333个氨基酸组成的蛋白质,具有一个中心SH 2结构域。酵母双杂交系统中的突变分析表明,GIPC PDZ结构域与IGF-I受体的羧基尾结合。GIPC二聚化,并且二聚化结构域已显示包括氨基末端结构域以及PDZ结构域的一部分。已被突变以阻止GIPC结合的IGF-I受体构建体已被转染到IGF-I受体缺失的小鼠胚胎成纤维细胞中,以探索GIPC在IGF-I受体信号传导中的功能。 我们已经开发了一种针对人IGF-I受体的小鼠单克隆抗体(4G 11)。该单克隆抗体阻断放射性标记的IGF-I与MCF-7乳腺癌细胞和MG-63骨肉瘤细胞的结合,并下调受体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

S P NISSLEY其他文献

S P NISSLEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('S P NISSLEY', 18)}}的其他基金

MECHANISM OF ACTION OF INSULIN-LIKE GROWTH FACTORS
胰岛素样生长因子的作用机制
  • 批准号:
    3751999
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MECHANISM OF ACTION OF INSULIN-LIKE GROWTH FACTORS
胰岛素样生长因子的作用机制
  • 批准号:
    3808484
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MECHANISM OF ACTION OF INSULIN-LIKE GROWTH FACTORS
胰岛素样生长因子的作用机制
  • 批准号:
    3916270
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Insulin-like Growth Factor I Receptor Signaling
胰岛素样生长因子 I 受体信号转导
  • 批准号:
    6558245
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MECHANISM OF ACTION OF INSULIN-LIKE GROWTH FACTORS
胰岛素样生长因子的作用机制
  • 批准号:
    3774284
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MECHANISM OF ACTION OF INSULIN-LIKE GROWTH FACTORS
胰岛素样生长因子的作用机制
  • 批准号:
    3939217
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MECHANISM OF ACTION OF INSULIN-LIKE GROWTH FACTORS
胰岛素样生长因子的作用机制
  • 批准号:
    5200914
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MECHANISM OF ACTION OF INSULIN-LIKE GROWTH FACTORS
胰岛素样生长因子的作用机制
  • 批准号:
    6123642
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MECHANISM OF ACTION OF INSULIN-LIKE GROWTH FACTORS
胰岛素样生长因子的作用机制
  • 批准号:
    3962925
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MECHANISM OF ACTION OF INSULIN-LIKE GROWTH FACTORS
胰岛素样生长因子的作用机制
  • 批准号:
    2456828
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
  • 批准号:
    6238317
  • 财政年份:
    1997
  • 资助金额:
    --
  • 项目类别:
CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
生物信号转导中的细胞粘附
  • 批准号:
    3732412
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
  • 批准号:
    5210031
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了